Enervit Valuation

Q: What is the Fair Price of 0N9T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

0N9T (€3.39) is trading above our estimate of [[fair value]] (€1.4)

Is 0N9T undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0N9T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0N9T (€3.39) is trading above our estimate of fair value (€1.4)

Significantly Below Fair Value: 0N9T is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0N9T?

Key metric: As 0N9T is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0N9T. This is calculated by dividing 0N9T's market cap by their current earnings.
What is 0N9T's PE Ratio?
PE Ratio	15.9x
Earnings	€3.73m
Market Cap	€59.27m

0N9T key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.9x
Enterprise Value/EBITDA	9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 0N9T's PE Ratio compare to its peers?

The above table shows the PE ratio for 0N9T vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	30.4x
VLG Venture Life Group	65.4x	67.1%	UK£48.5m
APN Applied Nutrition	25.6x	n/a	UK£348.8m
W7L Warpaint London	25x	11.8%	UK£427.6m
MCB McBride	5.6x	-0.2%	UK£185.4m
0N9T Enervit	15.9x	n/a	€59.3m

Price-To-Earnings vs Peers: 0N9T is expensive based on its Price-To-Earnings Ratio (15.9x) compared to the peer average (14.8x).

Price to Earnings Ratio vs Industry

How does 0N9T's PE Ratio compare vs other companies in the European Personal Products Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 0N9T is good value based on its Price-To-Earnings Ratio (15.9x) compared to the European Personal Products industry average (26.5x).

Price to Earnings Ratio vs Fair Ratio

What is 0N9T's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0N9T PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	15.9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0N9T's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ontex Group

€644.3m

Develops, produces, and supplies personal hygiene products and solutions for baby, feminine, and adult care in Belgium, the United Kingdom, the United States, Italy, France, and internationally.

0QVQ

€7.97

7.1%

11.9%

McBride

UK£185.4m

Manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Italy, Spain, rest of Europe, Asia-Pacific, and internationally.It operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.

MCBL

UK£1.07

2.4%

74.6%

Accrol Group Holdings

UK£123.7m

Engages in the soft tissue paper converting business in the United Kingdom and Europe.

ACRL

UK£0.39

9.6%